Neonatal dexamethasone and chronic tianeptine treatment inhibit ligature-induced periodontitis in adult rats

Journal of Periodontal Research

Volumn 41, Issue 1, 2006, Pages 23-32

  Breivik, Torbjørn ^a,b,c   Gundersen, Yngvar ^b   Osmundsen, Harald ^a   Fonnum, Frode ^b   Opstad, Per Kristian ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

^c NONE   (Norway)

Author keywords

Brain neuroendocrine immune regulation; Cytokines; Lipopolysaccharide; Periodontal disease; Rats

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXAMETHASONE; DEXAMETHASONE 21-PHOSPHATE; DEXAMETHASONE SODIUM PHOSPHATE; DRUG DERIVATIVE; GLUCOCORTICOID; LIPOPOLYSACCHARIDE; TGFB1 PROTEIN, RAT; THIAZEPINE DERIVATIVE; TIANEPTINE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA;

AGE; ANIMAL; ARTICLE; BLOOD; COMPARATIVE STUDY; DISEASE PREDISPOSITION; DOWN REGULATION; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; NEWBORN; OSTEOLYSIS; PERIODONTITIS; RAT; WISTAR RAT;

AGE FACTORS; ALVEOLAR BONE LOSS; ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEXAMETHASONE; DISEASE SUSCEPTIBILITY; DOWN-REGULATION; GLUCOCORTICOIDS; GRAM-NEGATIVE BACTERIA; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIPOPOLYSACCHARIDES; PERIODONTITIS; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR; THIAZEPINES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645048753     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2005.00833.x     Document Type: Article

References (63)

1. Tokoro Y, Matsuki Y, Yamamoto T, Suzuki T, Hara K. Relevance of local Th2-type cytokine mRNA expression in immunocompetent infiltrates in inflamed gingival tissue to periodontal diseases. Clin Exp Immunol 1997;107:166-174.
2. Chapple CC, Srivastava M, Hunter N. Failure of macrophage activation in destructive periodontal disease. J Pathol 1998;186:281-286.
3. Fokkema SJ, Loos BG, Siegte C, van der Velden U. A type 2 response in lipopolysaccharide (LPS)-stimulated whole blood cell cultures from periodontitis patients. Clin Exp Immunol 2002;127:374-378.
4. Breivik T, Rook GA. Oral treatment with SR299 (killed Mycobacterium vaccae) inhibits experimental periodontal disease in Wistar rats. J Clin Periodontol 2003;30:931-936.
5. Breivik T, Opstad PK, Engstad R, Gundersen G, Gjermo P, Preus H. Soluble β-1,3/1,6-glucan from yeast inhibits experimental periodontal disease in Wistar rats. J Clin Periodontol 2005: 32: 347-352.
6. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993;28:500-510.
7. Ding Y, Haapasalo M, Kerosuo E, Lounatmaa K, Kotiranta A, Sorsa T. Release and activation of human neutrophil matrix metallo- and serine proteinases during phagocytosis of Fusobacterium nucleatum, Porphyromonas gingivalis and Treponema denticola. J Clin Periodont 1997;24:237-248.
8. Lohinai Z, Benedek P, Fehér E et al. Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat. Br J Pharmacol 1998;123:353-360.
9. Michalowicz B. Genetic and heritable risk factors in periodontal disease. J Periodontol 1994;65:479-488.
10. Hugoson A, Jordan T. Frequency distribution of individuals aged 20-70 years according to severity of periodontal disease. Comm Dent Oral Epidemiol 1982;10:187-192.
11. Burt BA. Periodontitis and ageing: reviewing recent evidence. J Am Dent Assoc 1994;125:273-279.
12. Martinez-Canut P, Lorca A, Magan R. Smoking and periodontal disease severity. J Clin Periodontol 1996;22:743-749.
13. Thorstensson H, Hugoson A. Periodontal disease experience in adult long-duration insulin-dependent diabetics. J Clin Periodontol 1993;20:352-358.
14. Hugoson A, Ljungquist B, Breivik T. The relationship of some negative events and psychological factors to periodontal disease in an adult Swedish population 50-80 years of age. J Clin Periodontol 2002;29:247-253.
15. Wimmer G, Janda M, Wieselmann-Penkner K, Jakse N, Polansky R, Pertl C. Coping with stress: Its influence on periodontal disease. J Periodontol 2002;73:1343-1351.
16. Genco RJ, Ho AW, Grossi SG, Dunford RG, Tedesco LA. Relationship of stress, distress, and inadequate coping behaviors to periodontal disease. J Periodontol 1999;70:711723.
17. Breivik T, Thrane PS. Psychoneuroimmune interactions in periodontal disease. In: Ader R, Felten DL, Cohen N, eds. Psychoneuroimmunlogy, 3rd edn, Chapter 63. San Diego, CA: Academic Press, 2001: 627-644.
18. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-1361.
19. Elenkov IJ, Chrousos GP. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab 1999;10:359-368.
20. Lightman SL, Windle RJ, Ma XM et al. Hypothalamic-pituitary-adrenal function. Arch Physiol Biochem 2002;110:90-93.
21. Breivik T, Thrane PS, Gjermo P, Opstad PK, Pabst R, von Horsten S. Hypothalamic-pituitary-adrenal axis activation by experimental periodontal disease in rats. J Periodont Res 2001:36:295-300.
22. Breivik T, Opstad PK, Gjermo P, Thrane PS. Effects of hypothalamic-pituitary-adrenal axis reactivity on periodontal tissue destruction in rats. Eur J Oral Sci 2000;108:115-122.
23. Breivik T, Thrane PS, Gjermo P, Opstad PK. Glucocorticoid receptor antagonist RU-486 treatment reduces periodontitis in Fischer 344 rats. J Periodont Res 2000;35:285-290.
24. Breivik T, Gundersen Y, Osmundsen H, Opstad PK, Fonnum F. Chronic treatment with the glutamate receptor antagonist MK-801 alters periodontal disease susceptibility. J Periodont Res 2005;40:28-35.
25. Welberg LAM, Seckel JR. Prenatal stress, glucocorticoids and the programming of the brain. J Neuroendocrinol 2001;13:113-128.
26. Matthews SG. Early programming of the hypothamo-pituitary-adrenal axis. Trends Endocrinol Metabol 2002;13:373-380.
27. Kamphuis PJGH, Bakker JM, Broekhoven MH et al. Enhanced glucocorticoid feedback inhibition of hypothalamo-pituitary-adrenal responses to stress in adult rats neonatally treated with dexamethasone. Neuroendocrinol 2002:76:158-169.
28. Mammel MC, Johnson DE, Green TP, Thomson TR. Controlled trial of dexamathasone in infants with bronchopulmonary dysplasia. Lancet 1983;1:1356.
29. Bakker JM, Kavelaars A, Kamphuis PJGH et al. Neonatal dexamethasone treatment increases susceptibility to experimental autoimmune disease in adult rats. J Immunol 2000;165:5932-5937.
30. Shanks N, Larocque S, Meany M. Neonatal endotoxin exposure alters the development of the hypothalamic-pituitary-adrenal axis: Early illness and later responsivity to stress. J Neurosci 1995;15:376-384.
31. Sluyter F, Breivik T, Cools A. Manipulation in the maternal environment reverse genetically predisposed periodontitis in rats. Clin Diagn Lab Immunol 2002;4:931-932.
32. Breivik T, Stephan M, Brabant GE, Straub RH, Pabst R, von Hörsten S. Postnatal lipopolysaccharide-induced illness predisposes to periodontal disease in adulthood. Brain Behav Immunol 2002;16:421-438.
33. De Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998;19:269-301.
34. Czeh B, Michaelis T, Watanabe T et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by treatment with tianeptine. Pruc Natl Acad Sci USA 2001;98:12796-12801.
35. Castanon N, Mediana C, Mormende C, Danzer R. Chronic administration of tianeptine balances lipopolysaccharide-induced expression of cytokines in the spleen and hypothalamus of rats. Psychoneuroendocrinology 2004;29:778-779.
36. Conrad DC, Galea LAM, Kuroda Y, McEwen BS. Chronic stress impairs rat spatial memory on the Y maze and this effect is blocked by tianeptine pretreatment. Behav Neurosci 1996;110:1321-1334.
37. Malagie J, Deslandes A, Gardier AM. Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparition with paroxetine by using in vivo microdialysis. Eur J Pharmacol 2000;403:55-65.
38. Castanon N, Bluthe RM, Danzer R. Chronic treatment with the atypical anti-depressant tianeptine attenuates sickness behaviour induced by peripheral but not central lipopolysaccharide and interleukin-1 beta in the rat. Psychopharmacology 2001;154:50-60.
39. Castanon N, Konsman J-P, Mediana C, Chauvet N, Danzer R. Chronic treatment with the antidepressant tianeptine attenuates lipopolysaccharide- induced Fos expression in the rat paraventricular nucleus and HPA axis activation. Psychoneuroendocrinology 2003;28:9-34.
40. Fontantages R, Mimouni J, de Grieve X, Picard J, Pugeat M, Bange C. Effect of tianeptine on neuroendocrine, enzyme and behavioural responses to restraint stress in male rats. Eur J Psychiat 1993;8:67-73.
41. Delbende C, Tranchand Bunel D, Tarozzo G et al. Effect of chronic treatment with the antidepressant tianeptine on hypothalamic-pituitary-adrenal axis. Eur J Pharmacol 1994;251:245-251.
42. Felszeghy K, Gaspar E, Nyakas C. Long-term selective down-regulation of brain glucocorticoid receptors after neonatal dexamethasone treatment in rats. J Endocrinol 1996;8:483-499.
43. Zoli M, Agnati LF, Fuxe K et al. Long-lasting reduction of glucocorticoid receptor immunoreactvity in the hippocampus field CA1 but not in the dentate gyrus after neonatal treatment with corticosterone in the rat. Acta Physiol Scand 1990;138:577-579.
44. Plageman A, Straut A, Gotz F et al. Long-term effects of early postnatally administrated interleukin-1β on the hypothalic-piutary-adrenal (HPA) axis in rats. Endocrine Regul 1998:32:77-85.
45. Plotsky PM, Meany MJ. Early, postnatal experiences alters hypothalamic corticotrophin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Mol Brain Res 1993;18:195-200.
46. Liu D, Diorio J, Tannenbaum B et al. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 1997;277:1659-1662.
47. Kubera M, Maes M, Holand V, Basta-Kaim A, Roman A, Shani J. Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. J Affect Disord 2001;63:171-178.
48. Cassano GB, Heinze G, Loo H, Mendlewicz J., Paes de Sousa M. A double-blind comparison of tianeptine, imipramine and placebo in the treatment of major depressive episodes. Eur Psychiatry 1996;11:254-259.
49. Costa de Silva JA, Ruschel SI, Caetano D et al. Placebo-controlled study of tianeptine in major depressive episodes. Neuropsychobiol 1997;35:24-29.
50. Wagstaff AJ, Ormrod D, Spencer CM. Tianeptine. A review of its use in depressive disorders. CNS Drugs 2001;15:231-259.
51. McEwen BS. Stress and hippocampal plasticity. Ann Rev Neurosci 1999;20:9104-9110.
52. Malberg JE, Eisch AJ, Nesler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000;20:9104-9110.
53. Kole MHP, Swan L, Fuchs E. The anti-depressant tianeptine persistently modulates glutamate receptor currents of the hippocampal CA3 commissural associational synapse in chronically stressed rats. Eur J Neurosci 2002;16:807-816.
54. Leonard BE. The immune system, depression and the action of antidepressants. Prog Neuro-Psychopharmacol Biol Psychiat 2001;25:767-780.
55. Breivik T., Thrane PS, Gjermo P, Cools A, Myhrer T. Effects of hippocampal lesioning on experimental periodontal disease in Wistar rats. J Periodont Res 2002;37:360-365.
56. Breivik T, Thrane PS, Gjermo P, Fonnum F. Postnatal glutamate-induced central nervous system lesions alter periodontal disease susceptibility in adult Wistar rats. J Clin Periodontol 2001;28:904-909.
57. Mascarucci P, Perego C, Tarrazzino S, Simoni MG. Glutamate release in the nucleus tractus solitarius induced by peripheral lipopolysaccharide and interleukin-1β. Neuroscience 1998;86:1285-1290.
58. Ziegler AR, Basil AS. Glutamate augments retrovirus-induced immunodeficiency through stimulation of the hypothalamic-pituitary-adrenal axis. J Immunol 1999;162:4998-5002.
59. Ziegler DR, Herman JP. Local integration of glutamate signalling in the hypothalamic paraventricular region: regulation of glucocorticoid stress responses. Endocrinology 2000;141:4801-4804.
60. Breivik T, Gundersen Y, Osmundsen H, Opstad P-K, Fonnum F. Chronic glycine treatment inhibits ligature-induced periodontal disease in Wistar rats. J Periodont Res 2005;40:43-47.
61. Gold PM, Licinio J, Wong ML. Corticotropin-releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann N Y Acad Sci 1995;771:716-729.
62. Breivik T, Gundersen Y, Opstad PK, Fonnum F. Chemical sympathectomy inhibits periodontal disease in Fischer 344 rats. J Periodont Res 2005;40:325-330.
63. Xia Z, De Poere J W, Nassberger L. TCA's inhibit IL-1, IL-6 and TNF release in human blood monocytes and IL-2 and interferon in T-cells. Immunopharmacology 1991;34:27-37.